New OptiForm® Solution Suite
Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.
Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.
The new service includes more comprehensive candidate screening tools, ADME considerations and in silico DMPK modeling, as well as additional bioavailability enhancing tools, to provide materials for cGLP toxicological studies, and on to first-in-human studies.
Catalent Pharma Solutions
14 Schoolhouse Rd, Somerset, NJ 08873
tel. +1.888.SOLUTION (765.8846)
AAPS Booth #3016
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
